{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:33:53Z","timestamp":1786361633523,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-026-03067-6","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:11:24Z","timestamp":1786360284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology"],"prefix":"10.1007","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0208-2396","authenticated-orcid":false,"given":"William","family":"Gehin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Sophie","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Harle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"3067_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/clinchem\/hvad115","volume":"70","author":"A-K Afflerbach","year":"2024","unstructured":"Afflerbach A-K, Rohrandt C, Br\u00e4ndl B, S\u00f6nksen M, Hench J, Frank S et al (2024) Classification of brain tumors by nanopore sequencing of cell-free DNA from cerebrospinal fluid. Clin Chem 70:250\u2013260. https:\/\/doi.org\/10.1093\/clinchem\/hvad115","journal-title":"Clin Chem"},{"key":"3067_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1268038","volume":"17","author":"A d\u2019 Amati","year":"2024","unstructured":"d\u2019Amati A, Bargiacchi L, Rossi S, Carai A, Bertero L, Barresi V et al (2024) Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists? Front Mol Neurosci 17:1268038. https:\/\/doi.org\/10.3389\/fnmol.2024.1268038","journal-title":"Front Mol Neurosci"},{"key":"3067_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00401-024-02795-x","volume":"148","author":"S An","year":"2024","unstructured":"An S, McCortney K, Walshon J, Leonard K, Wray B, McCord M et al (2024) Methylation profiling of plasma cell-free DNA in pediatric brain tumor patients. Acta Neuropathol (Berl) 148:29. https:\/\/doi.org\/10.1007\/s00401-024-02795-x","journal-title":"Acta Neuropathol (Berl)"},{"key":"3067_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-020-01056-8","volume":"8","author":"C Antin","year":"2020","unstructured":"Antin C, Tauzi\u00e8de-Espariat A, Debily M-A, Castel D, Grill J, Pag\u00e8s M et al (2020) EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression. Acta Neuropathol Commun 8:183. https:\/\/doi.org\/10.1186\/s40478-020-01056-8","journal-title":"Acta Neuropathol Commun"},{"key":"3067_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41698-024-00535-8","volume":"8","author":"C Arthur","year":"2024","unstructured":"Arthur C, Carlson L-M, Svoboda J, Sandvik U, Jylh\u00e4 C, Nordenskj\u00f6ld M et al (2024) Liquid biopsy guides successful molecular targeted therapy of an inoperable pediatric brainstem neoplasm. NPJ Precis Oncol 8:44. https:\/\/doi.org\/10.1038\/s41698-024-00535-8","journal-title":"NPJ Precis Oncol"},{"key":"3067_CR6","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00921","volume":"9","author":"SJ Bagley","year":"2025","unstructured":"Bagley SJ, Beaubier N, Balaj L, Bettegowda C, Carpenter E, Carter BS et al (2025) Minimum technical preanalytical, patient, and clinical context data elements for cerebrospinal fluid liquid biopsy: recommendations for public database submissions. JCO Precis Oncol 9:e2400921. https:\/\/doi.org\/10.1200\/PO-24-00921","journal-title":"JCO Precis Oncol"},{"key":"3067_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41591-024-03435-3","volume":"31","author":"B Br\u00e4ndl","year":"2025","unstructured":"Br\u00e4ndl B, Steiger M, Kubelt C, Rohrandt C, Zhu Z, Evers M et al (2025) Rapid brain tumor classification from sparse epigenomic data. Nat Med 31:840\u2013848. https:\/\/doi.org\/10.1038\/s41591-024-03435-3","journal-title":"Nat Med"},{"key":"3067_CR8","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1158\/1078-0432.CCR-20-2066","volume":"26","author":"AK Bruzek","year":"2020","unstructured":"Bruzek AK, Ravi K, Muruganand A, Wadden J, Babila CM, Cantor E et al (2020) Electronic DNA analysis of CSF cell-free tumor DNA to quantify multi-gene molecular response in pediatric high-grade glioma. Clin Cancer Res 26:6266\u20136276. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2066","journal-title":"Clin Cancer Res"},{"key":"3067_CR9","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/neuonc\/noac030","volume":"24","author":"E Cantor","year":"2022","unstructured":"Cantor E, Wierzbicki K, Tarapore RS, Ravi K, Thomas C, Cartaxo R et al (2022) Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. Neuro-Oncol 24:1366\u20131374. https:\/\/doi.org\/10.1093\/neuonc\/noac030","journal-title":"Neuro-Oncol"},{"key":"3067_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"3067_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B et al (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737-754.e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.005","journal-title":"Cancer Cell"},{"key":"3067_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1158\/1055-9965.EPI-18-0586","volume":"28","author":"L Cavallone","year":"2019","unstructured":"Cavallone L, Aldamry M, Lafleur J, Lan C, Gonzalez Ginestet P, Alirezaie N et al (2019) A study of pre-analytical variables and optimization of extraction method for circulating tumor DNA measurements by digital droplet PCR. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 28:909\u2013916. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0586","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"3067_CR13","doi-asserted-by":"publisher","first-page":"i152","DOI":"10.1093\/neuonc\/noac079.565","volume":"24","author":"B Cole","year":"2022","unstructured":"Cole B, Lockwood C, Paulson V, Lee A, Hauptman J, Goldstein H et al (2022) OTHR-26. A pilot study of clinical minimal residual disease detection in pediatric embryonal brain tumors. Neuro-oncol 24:i152\u2013i153. https:\/\/doi.org\/10.1093\/neuonc\/noac079.565","journal-title":"Neuro-oncol"},{"key":"3067_CR14","unstructured":"Congressional Research Service (2025) FDA regulation of laboratory-developed tests (LDTs). CRS In Focus IF11389. Congressional Research Service, Washington, DC. https:\/\/crsreports.congress.gov\/product\/pdf\/IF\/IF11389. Accessed Apr 2026"},{"key":"3067_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01696-w","volume":"16","author":"L Cornelli","year":"2024","unstructured":"Cornelli L, Van Paemel R, Ferro Dos Santos MR, Roelandt S, Willems L, Vandersteene J et al (2024) Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid. Clin Epigenetics 16:87. https:\/\/doi.org\/10.1186\/s13148-024-01696-w","journal-title":"Clin Epigenetics"},{"key":"3067_CR16","doi-asserted-by":"publisher","first-page":"vdae126","DOI":"10.1093\/noajnl\/vdae126","volume":"6","author":"EE Crotty","year":"2024","unstructured":"Crotty EE, Paulson VA, Ronsley R, Vitanza NA, Lee A, Hauptman J et al (2024) Cerebrospinal fluid liquid biopsy by low-pass whole genome sequencing for clinical disease monitoring in pediatric embryonal tumors. Neuro-Oncol Adv 6:vdae126. https:\/\/doi.org\/10.1093\/noajnl\/vdae126","journal-title":"Neuro-Oncol Adv"},{"key":"3067_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9839","volume":"6","author":"L De Mattos-Arruda","year":"2015","unstructured":"De Mattos-Arruda L, Mayor R, Ng CKY, Weigelt B, Mart\u00ednez-Ricarte F, Torrejon D et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6:8839. https:\/\/doi.org\/10.1038\/ncomms9839","journal-title":"Nat Commun"},{"key":"3067_CR18","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/neuonc\/noaf103","volume":"27","author":"S Deacon","year":"2025","unstructured":"Deacon S, Cahyani I, Holmes N, Fox G, Munro R, Wibowo S et al (2025) ROBIN: a unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis. Neuro-oncol 27:2035\u20132046. https:\/\/doi.org\/10.1093\/neuonc\/noaf103","journal-title":"Neuro-oncol"},{"key":"3067_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19175-0","volume":"11","author":"L Escudero","year":"2020","unstructured":"Escudero L, Llort A, Arias A, Diaz-Navarro A, Mart\u00ednez-Ricarte F, Rubio-Perez C et al (2020) Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma. Nat Commun 11:5376. https:\/\/doi.org\/10.1038\/s41467-020-19175-0","journal-title":"Nat Commun"},{"key":"3067_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02024-w","volume":"13","author":"TT Fischer","year":"2025","unstructured":"Fischer TT, Maa\u00df KK, Puranachot P, Mieskolainen M, Sill M, Schad PS et al (2025) Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort. Acta Neuropathol Commun 13:134. https:\/\/doi.org\/10.1186\/s40478-025-02024-w","journal-title":"Acta Neuropathol Commun"},{"key":"3067_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/neuonc\/noz244","volume":"22","author":"MC Fr\u00fchwald","year":"2020","unstructured":"Fr\u00fchwald MC, Hasselblatt M, Nemes K, Bens S, Steinb\u00fcgl M, Johann PD et al (2020) Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid\/rhabdoid tumors. Neuro-oncol 22:1006\u20131017. https:\/\/doi.org\/10.1093\/neuonc\/noz244","journal-title":"Neuro-oncol"},{"key":"3067_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114201","volume":"208","author":"B Geoerger","year":"2024","unstructured":"Geoerger B, Bautista F, Andr\u00e9 N, Berlanga P, Gatz SA, Marshall LV et al (2024) Precision cancer medicine platform trials: concepts and design of AcS\u00e9-ESMART. Eur J Cancer 208:114201. https:\/\/doi.org\/10.1016\/j.ejca.2024.114201","journal-title":"Eur J Cancer"},{"key":"3067_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112683","volume":"14","author":"L Greuter","year":"2022","unstructured":"Greuter L, Frank N, Guzman R, Soleman J (2022) The clinical applications of liquid biopsies in pediatric brain tumors: a systematic literature review. Cancers 14:2683. https:\/\/doi.org\/10.3390\/cancers14112683","journal-title":"Cancers"},{"key":"3067_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/neuped\/wuaf001.267","volume":"1","author":"K Hill","year":"2025","unstructured":"Hill K, Larsen AG, Hickman R, Ucpinar BA, Alano T, Doe-Tetteh S et al (2025) OTHR-08. Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing. Neuro-Oncol Pediatr 1:wuaf001.267. https:\/\/doi.org\/10.1093\/neuped\/wuaf001.267","journal-title":"Neuro-Oncol Pediatr"},{"key":"3067_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/neuonc\/noz235","volume":"22","author":"B Ho","year":"2020","unstructured":"Ho B, Johann PD, Grabovska Y, De Dieu Andrianteranagna MJ, Yao F, Fr\u00fchwald M et al (2020) Molecular subgrouping of atypical teratoid\/rhabdoid tumors-a reinvestigation and current consensus. Neuro-oncol 22:613\u2013624. https:\/\/doi.org\/10.1093\/neuonc\/noz235","journal-title":"Neuro-oncol"},{"key":"3067_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","volume":"5","author":"TY Huang","year":"2017","unstructured":"Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T et al (2017) Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5:28. https:\/\/doi.org\/10.1186\/s40478-017-0436-6","journal-title":"Acta Neuropathol Commun"},{"key":"3067_CR27","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1158\/1078-0432.CCR-23-2907","volume":"30","author":"F Iser","year":"2024","unstructured":"Iser F, Hinz F, Hoffmann DC, Grassl N, G\u00fcngo\u00f6r C, Meyer J et al (2024) Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma. Clin Cancer Res Off J Am Assoc Cancer Res 30:2974\u20132985. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-2907","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"3067_CR28","doi-asserted-by":"publisher","first-page":"vdab013","DOI":"10.1093\/noajnl\/vdab013","volume":"3","author":"E Izquierdo","year":"2021","unstructured":"Izquierdo E, Proszek P, Pericoli G, Temelso S, Clarke M, Carvalho DM et al (2021) Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients. Neuro-Oncol Adv 3:vdab013. https:\/\/doi.org\/10.1093\/noajnl\/vdab013","journal-title":"Neuro-Oncol Adv"},{"key":"3067_CR29","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/neuonc\/noad032","volume":"25","author":"M Kojic","year":"2023","unstructured":"Kojic M, Maybury MK, Waddell N, Koufariotis LT, Addala V, Millar A et al (2023) Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening. Neuro-Oncol 25:1507\u20131517. https:\/\/doi.org\/10.1093\/neuonc\/noad032","journal-title":"Neuro-Oncol"},{"key":"3067_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1373\/clinchem.2019.306837","volume":"66","author":"R Lampignano","year":"2020","unstructured":"Lampignano R, Neumann MHD, Weber S, Kloten V, Herdean A, Voss T et al (2020) Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (pre)analytical work flows. Clin Chem 66:149\u2013160. https:\/\/doi.org\/10.1373\/clinchem.2019.306837","journal-title":"Clin Chem"},{"key":"3067_CR31","doi-asserted-by":"publisher","first-page":"eabb5427","DOI":"10.1126\/sciadv.abb5427","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Zhao S, Lee M, Yin Y, Li J, Zhou Y et al (2020) Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma. Sci Adv 6:eabb5427. https:\/\/doi.org\/10.1126\/sciadv.abb5427","journal-title":"Sci Adv"},{"key":"3067_CR32","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.ccell.2021.09.012","volume":"39","author":"APY Liu","year":"2021","unstructured":"Liu APY, Smith KS, Kumar R, Paul L, Bihannic L, Lin T et al (2021) Serial assessment of measurable residual disease in medulloblastoma liquid biopsies. Cancer Cell 39:1519-1530.e4. https:\/\/doi.org\/10.1016\/j.ccell.2021.09.012","journal-title":"Cancer Cell"},{"key":"3067_CR33","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-oncol"},{"key":"3067_CR34","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/j.wneu.2023.09.003","volume":"179","author":"VM Lu","year":"2023","unstructured":"Lu VM, Elarjani T, Niazi TN (2023) Global, regional, and national incidence and mortality trends in pediatric central nervous system tumors over the past 2 decades. World Neurosurg 179:e568\u2013e574. https:\/\/doi.org\/10.1016\/j.wneu.2023.09.003","journal-title":"World Neurosurg"},{"key":"3067_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00401-023-02567-z","volume":"145","author":"S Madlener","year":"2023","unstructured":"Madlener S, Furtner J, Stepien N, Senfter D, Mayr L, Zeyda M et al (2023) Clinical applicability of miR517a detection in liquid biopsies of ETMR patients. Acta Neuropathol (Berl) 145:843\u2013846. https:\/\/doi.org\/10.1007\/s00401-023-02567-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"3067_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-024-02842-7","volume":"149","author":"S Madlener","year":"2025","unstructured":"Madlener S, Stepien N, Senfter D, Mayr L, Laemmerer A, Hedrich C et al (2025) Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method. Acta Neuropathol (Berl) 149:5. https:\/\/doi.org\/10.1007\/s00401-024-02842-7","journal-title":"Acta Neuropathol (Berl)"},{"key":"3067_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41698-025-01067-5","volume":"9","author":"AL Markowitz","year":"2025","unstructured":"Markowitz AL, Munugula C, Christodoulou E, Ji J, Xu L, Cotter JA et al (2025) Genome-wide cfDNA fragmentation patterns in cerebrospinal fluid reflect medulloblastoma groups. NPJ Precis Oncol 9:280. https:\/\/doi.org\/10.1038\/s41698-025-01067-5","journal-title":"NPJ Precis Oncol"},{"key":"3067_CR38","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1200\/JCO.23.01621","volume":"42","author":"N Mikolajewicz","year":"2024","unstructured":"Mikolajewicz N, Yee PP, Bhanja D, Trifoi M, Miller AM, Metellus P et al (2024) Systematic review of cerebrospinal fluid biomarker discovery in neuro-oncology: a roadmap to standardization and clinical application. J Clin Oncol 42:1961\u20131974. https:\/\/doi.org\/10.1200\/JCO.23.01621","journal-title":"J Clin Oncol"},{"key":"3067_CR39","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.6004\/jnccn.2022.7093","volume":"20","author":"AM Miller","year":"2022","unstructured":"Miller AM, Karajannis MA (2022) Current role and future potential of CSF ctDNA for the diagnosis and clinical management of pediatric central nervous system tumors. J Natl Compr Cancer Netw 20:1363\u20131369. https:\/\/doi.org\/10.6004\/jnccn.2022.7093","journal-title":"J Natl Compr Cancer Netw"},{"key":"3067_CR40","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","volume":"565","author":"AM Miller","year":"2019","unstructured":"Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N et al (2019) Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565:654\u2013658. https:\/\/doi.org\/10.1038\/s41586-019-0882-3","journal-title":"Nature"},{"key":"3067_CR41","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/neuonc\/noac035","volume":"24","author":"AM Miller","year":"2022","unstructured":"Miller AM, Szalontay L, Bouvier N, Hill K, Ahmad H, Rafailov J et al (2022) Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients. Neuro-Oncol 24:1763\u20131772. https:\/\/doi.org\/10.1093\/neuonc\/noac035","journal-title":"Neuro-Oncol"},{"key":"3067_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2023.08.010","volume":"278\u2013279","author":"K Miller","year":"2023","unstructured":"Miller K, Wilson S, Rivaldi A, Grischow O, Lucyshyn J, Venkata L et al (2023) 2. Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumors. Cancer Genet 278\u2013279:1. https:\/\/doi.org\/10.1016\/j.cancergen.2023.08.010","journal-title":"Cancer Genet"},{"key":"3067_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/bjc.2015.429","volume":"114","author":"MJ Murray","year":"2016","unstructured":"Murray MJ, Bell E, Raby KL, Rijlaarsdam MA, Gillis AJM, Looijenga LHJ et al (2016) A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer 114:151\u2013162. https:\/\/doi.org\/10.1038\/bjc.2015.429","journal-title":"Br J Cancer"},{"key":"3067_CR44","first-page":"E148","volume":"56","author":"M Nishihara","year":"2011","unstructured":"Nishihara M, Sasayama T, Kudo H, Kohmura E (2011) Morbidity of stereotactic biopsy for intracranial lesions. Kobe J Med Sci 56:E148-153","journal-title":"Kobe J Med Sci"},{"key":"3067_CR45","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1093\/neuonc\/noae064.031","volume":"26","author":"L Nobre","year":"2024","unstructured":"Nobre L, Nakano Y, Burns I, Johnson M, Sheth J, Rana M et al (2024) BIOM-12. Liquid biopsies in CNS tumors: a combined approach to profiling CSF. Neuro-oncol 26:0\u20130. https:\/\/doi.org\/10.1093\/neuonc\/noae064.031","journal-title":"Neuro-oncol"},{"key":"3067_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/clinchem\/hvae140","volume":"71","author":"K O\u2019Halloran","year":"2025","unstructured":"O\u2019Halloran K, Christodoulou E, Paulson VA, Cole BL, Margol AS, Biegel JA et al (2025) Low-pass whole genome sequencing of cell-free DNA from cerebrospinal fluid: a focus on pediatric central nervous system tumors. Clin Chem 71:87\u201396. https:\/\/doi.org\/10.1093\/clinchem\/hvae140","journal-title":"Clin Chem"},{"key":"3067_CR47","doi-asserted-by":"publisher","first-page":"vdad077","DOI":"10.1093\/noajnl\/vdad077","volume":"5","author":"K O\u2019Halloran","year":"2023","unstructured":"O\u2019Halloran K, Yellapantula V, Christodoulou E, Ostrow D, Bootwalla M, Ji J et al (2023) Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors. Neuro-Oncol Adv 5:vdad077. https:\/\/doi.org\/10.1093\/noajnl\/vdad077","journal-title":"Neuro-Oncol Adv"},{"key":"3067_CR48","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol 20:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"3067_CR49","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/neuonc\/noab299","volume":"24","author":"M Pag\u00e8s","year":"2022","unstructured":"Pag\u00e8s M, Rotem D, Gydush G, Reed S, Rhoades J, Ha G et al (2022) Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine. Neuro-oncol 24:1352\u20131363. https:\/\/doi.org\/10.1093\/neuonc\/noab299","journal-title":"Neuro-oncol"},{"key":"3067_CR50","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","volume":"24","author":"E Panditharatna","year":"2018","unstructured":"Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN et al (2018) Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res 24:5850\u20135859. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1345","journal-title":"Clin Cancer Res"},{"key":"3067_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00401-022-02415-6","volume":"143","author":"A Patel","year":"2022","unstructured":"Patel A, Dogan H, Payne A, Krause E, Sievers P, Schoebe N et al (2022) Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study. Acta Neuropathol 143:609\u2013612. https:\/\/doi.org\/10.1007\/s00401-022-02415-6","journal-title":"Acta Neuropathol"},{"key":"3067_CR52","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","volume":"34","author":"EI Pentsova","year":"2016","unstructured":"Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S et al (2016) Evaluating cancer of the Central Nervous System through next-generation sequencing of cerebrospinal fluid. J Clin Oncol 34:2404\u20132415. https:\/\/doi.org\/10.1200\/JCO.2016.66.6487","journal-title":"J Clin Oncol"},{"key":"3067_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11060-024-04645-y","volume":"168","author":"R Ronsley","year":"2024","unstructured":"Ronsley R, Karvonen KA, Cole B, Paulson V, Stevens J, Crotty EE et al (2024) Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors. J Neurooncol 168:215\u2013224. https:\/\/doi.org\/10.1007\/s11060-024-04645-y","journal-title":"J Neurooncol"},{"key":"3067_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-014-1432-3","volume":"118","author":"N Samuel","year":"2014","unstructured":"Samuel N, Remke M, Rutka JT, Raught B, Malkin D (2014) Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors. J Neurooncol 118:225\u2013238. https:\/\/doi.org\/10.1007\/s11060-014-1432-3","journal-title":"J Neurooncol"},{"key":"3067_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-019-02020-0","volume":"138","author":"T Sharma","year":"2019","unstructured":"Sharma T, Schwalbe EC, Williamson D, Sill M, Hovestadt V, Mynarek M et al (2019) Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol (Berl) 138:309\u2013326. https:\/\/doi.org\/10.1007\/s00401-019-02020-0","journal-title":"Acta Neuropathol (Berl)"},{"key":"3067_CR56","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D et al (2018) Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563:579\u2013583. https:\/\/doi.org\/10.1038\/s41586-018-0703-0","journal-title":"Nature"},{"key":"3067_CR57","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1093\/neuonc\/noae064.028","volume":"26","author":"N Simon","year":"2024","unstructured":"Simon N, Maass KK, Pokorn\u00e1 P, Stepien N, Rettenmeier J, Saijonmaa O et al (2024) BIOM-09. Towards clinical implementation of liquid biopsy analysis for paediatric brain tumour patients \u2013 a pan-European effort for standardization. Neuro-oncol 26:0\u20130. https:\/\/doi.org\/10.1093\/neuonc\/noae064.028","journal-title":"Neuro-oncol"},{"key":"3067_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-026-01115-4","author":"KS Smith","year":"2026","unstructured":"Smith KS, Fischer TT, Han K, Kostecka A, Lin H, Senfter D et al (2026) M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors. Nat Cancer. https:\/\/doi.org\/10.1038\/s43018-026-01115-4","journal-title":"Nat Cancer"},{"key":"3067_CR59","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3343\/alm.2023.0267","volume":"44","author":"HH Song","year":"2024","unstructured":"Song HH, Park H, Cho D, Bang HI, Oh H-J, Kim J (2024) Optimization of a protocol for isolating cell-free DNA from cerebrospinal fluid. Ann Lab Med 44:294\u2013298. https:\/\/doi.org\/10.3343\/alm.2023.0267","journal-title":"Ann Lab Med"},{"key":"3067_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0580-7","volume":"6","author":"S Stallard","year":"2018","unstructured":"Stallard S, Savelieff MG, Wierzbicki K, Mullan B, Miklja Z, Bruzek A et al (2018) CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response. Acta Neuropathol Commun 6:80. https:\/\/doi.org\/10.1186\/s40478-018-0580-7","journal-title":"Acta Neuropathol Commun"},{"key":"3067_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.957944","volume":"10","author":"R Stankunaite","year":"2022","unstructured":"Stankunaite R, Marshall LV, Carceller F, Chesler L, Hubank M, George SL (2022) Liquid biopsy for children with central nervous system tumours: clinical integration and technical considerations. Front Pediatr 10:957944. https:\/\/doi.org\/10.3389\/fped.2022.957944","journal-title":"Front Pediatr"},{"key":"3067_CR62","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1093\/neuonc\/noae064.711","volume":"26","author":"N Stepien","year":"2024","unstructured":"Stepien N, Senfter D, Freund J, Machreich S, Bruckner K, Mager L et al (2024) PATH-08. Pre-operative tumour classification using nanopore sequencing of cerebrospinal fluid. Neuro Oncol 26:0\u20130. https:\/\/doi.org\/10.1093\/neuonc\/noae064.711","journal-title":"Neuro Oncol"},{"key":"3067_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092525","volume":"15","author":"N Stepien","year":"2023","unstructured":"Stepien N, Senfter D, Furtner J, Haberler C, Dorfer C, Czech T et al (2023) Proof-of-concept for liquid biopsy disease monitoring of MYC-amplified group 3 medulloblastoma by droplet digital PCR. Cancers 15:2525. https:\/\/doi.org\/10.3390\/cancers15092525","journal-title":"Cancers"},{"key":"3067_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nbt.2022.10.001","volume":"72","author":"P Takousis","year":"2022","unstructured":"Takousis P, Devonshire AS, Redshaw N, von Baumgarten L, Whale AS, Jones GM et al (2022) A standardised methodology for the extraction and quantification of cell-free DNA in cerebrospinal fluid and application to evaluation of Alzheimer\u2019s disease and brain cancers. New Biotechnol 72:97\u2013106. https:\/\/doi.org\/10.1016\/j.nbt.2022.10.001","journal-title":"New Biotechnol"},{"key":"3067_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae064.246","author":"LT Tam","year":"2024","unstructured":"Tam LT, Rossi G, Stevens J, Ronsley R, Vitanza NA, Cole BL et al (2024) Metb-05. CSF liquid biopsy: paving the way for minimally invasive brain tumor surveillance using low-pass whole genome sequencing. Neuro-Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noae064.246","journal-title":"Neuro-Oncol"},{"key":"3067_CR66","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M et al (2009) A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73:1914\u20131922. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c47cc2","journal-title":"Neurology"},{"key":"3067_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1114762","volume":"13","author":"A Tripathy","year":"2022","unstructured":"Tripathy A, John V, Wadden J, Kong S, Sharba S, Koschmann C (2022) Liquid biopsy in pediatric brain tumors. Front Genet 13:1114762. https:\/\/doi.org\/10.3389\/fgene.2022.1114762","journal-title":"Front Genet"},{"key":"3067_CR68","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1073\/pnas.1511694112","volume":"112","author":"Y Wang","year":"2015","unstructured":"Wang Y, Springer S, Zhang M, McMahon KW, Kinde I, Dobbyn L et al (2015) Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc Natl Acad Sci U S A 112:9704\u20139709. https:\/\/doi.org\/10.1073\/pnas.1511694112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3067_CR69","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/neuonc\/noac264","volume":"25","author":"JA Zuccato","year":"2023","unstructured":"Zuccato JA, Patil V, Mansouri S, Voisin M, Chakravarthy A, Shen SY et al (2023) Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. Neuro-oncol 25:1452\u20131460. https:\/\/doi.org\/10.1093\/neuonc\/noac264","journal-title":"Neuro-oncol"},{"key":"3067_CR70","unstructured":"Regulation (EU) (2017) 2017\/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98\/79\/EC and Commission Decision 2010\/227\/EU"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-03067-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:11:27Z","timestamp":1786360287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-03067-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3067"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-03067-6","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}